Distinct cellular origins of primary effusion lymphoma with and without EBV infection

Rifat Hamoudi, Tim C. Diss, Eric Oksenhendler, Langxing Pan, Antonino Carbone, Valeria Ascoli, Chris Boshoff, Peter Isaacson, Ming Qing Du

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) is associated with three distinct lymphoproliferative disorders: primary effusion lymphoma (PEL), multicentric Castleman's disease (MCD) and germinotropic lymphoproliferative disorder (GLD). KSHV positive lymphocytes in GLD and in most cases of PEL are co-infected by Epstein-Barr virus (EBV) and these viral double positive cells harbour mutated rearranged immunoglobulin (Ig) genes, suggesting that they originate from germinal centre or post-germinal centre B-cells. In contrast, KSHV positive cells in MCD are invariably negative for EBV, do not carry Ig gene mutation and are believed to originate from naïve IgMλ expressing B-cells. Interestingly, one EBV negative PEL (BC3) also lacks Ig gene mutation, raising the question whether KSHV preferentially targets naïve B-cells in the absence of EBV. We compared the cellular origin of PEL with and without EBV infection by analysis of Ig gene mutation. High molecular weight DNA from 17 PELs was subjected to PCR of the rearranged Ig heavy and light chain genes. Successful amplification was achieved from eight cases (four EBV positive and four EBV negative) and the PCR products were sequenced. All four EBV positive PEL showed variable levels of mutation in their rearranged VH or VL genes, ranging from 4 to 7%. In contrast, two of the four EBV negative PELs including BC3 displayed absence of mutation in their rearranged Ig genes. Our results indicate that EBV positive PELs are derived from germinal centre or post-germinal centre B-cells, whereas EBV negative PELs may originate from either germinal/post-germinal centre or naïve B-cells.

Original languageEnglish
Pages (from-to)333-338
Number of pages6
JournalLeukemia Research
Volume28
Issue number4
DOIs
Publication statusPublished - Apr 2004

Fingerprint

Primary Effusion Lymphoma
Epstein-Barr Virus Infections
Human Herpesvirus 4
Immunoglobulin Genes
Germinal Center
Human Herpesvirus 8
B-Lymphocytes
Lymphoproliferative Disorders
Mutation
Immunoglobulin Light Chain Genes
Immunoglobulin Heavy Chain Genes
Polymerase Chain Reaction
Immunoglobulin M
Molecular Weight

Keywords

  • EBV
  • Ig gene
  • Mutation
  • Primary effusion lymphoma

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Hamoudi, R., Diss, T. C., Oksenhendler, E., Pan, L., Carbone, A., Ascoli, V., ... Du, M. Q. (2004). Distinct cellular origins of primary effusion lymphoma with and without EBV infection. Leukemia Research, 28(4), 333-338. https://doi.org/10.1016/j.leukres.2003.08.003

Distinct cellular origins of primary effusion lymphoma with and without EBV infection. / Hamoudi, Rifat; Diss, Tim C.; Oksenhendler, Eric; Pan, Langxing; Carbone, Antonino; Ascoli, Valeria; Boshoff, Chris; Isaacson, Peter; Du, Ming Qing.

In: Leukemia Research, Vol. 28, No. 4, 04.2004, p. 333-338.

Research output: Contribution to journalArticle

Hamoudi, R, Diss, TC, Oksenhendler, E, Pan, L, Carbone, A, Ascoli, V, Boshoff, C, Isaacson, P & Du, MQ 2004, 'Distinct cellular origins of primary effusion lymphoma with and without EBV infection', Leukemia Research, vol. 28, no. 4, pp. 333-338. https://doi.org/10.1016/j.leukres.2003.08.003
Hamoudi R, Diss TC, Oksenhendler E, Pan L, Carbone A, Ascoli V et al. Distinct cellular origins of primary effusion lymphoma with and without EBV infection. Leukemia Research. 2004 Apr;28(4):333-338. https://doi.org/10.1016/j.leukres.2003.08.003
Hamoudi, Rifat ; Diss, Tim C. ; Oksenhendler, Eric ; Pan, Langxing ; Carbone, Antonino ; Ascoli, Valeria ; Boshoff, Chris ; Isaacson, Peter ; Du, Ming Qing. / Distinct cellular origins of primary effusion lymphoma with and without EBV infection. In: Leukemia Research. 2004 ; Vol. 28, No. 4. pp. 333-338.
@article{f802e36f9455474e8c99fc2a9a2c1a5b,
title = "Distinct cellular origins of primary effusion lymphoma with and without EBV infection",
abstract = "Kaposi's sarcoma-associated herpesvirus (KSHV) is associated with three distinct lymphoproliferative disorders: primary effusion lymphoma (PEL), multicentric Castleman's disease (MCD) and germinotropic lymphoproliferative disorder (GLD). KSHV positive lymphocytes in GLD and in most cases of PEL are co-infected by Epstein-Barr virus (EBV) and these viral double positive cells harbour mutated rearranged immunoglobulin (Ig) genes, suggesting that they originate from germinal centre or post-germinal centre B-cells. In contrast, KSHV positive cells in MCD are invariably negative for EBV, do not carry Ig gene mutation and are believed to originate from na{\"i}ve IgMλ expressing B-cells. Interestingly, one EBV negative PEL (BC3) also lacks Ig gene mutation, raising the question whether KSHV preferentially targets na{\"i}ve B-cells in the absence of EBV. We compared the cellular origin of PEL with and without EBV infection by analysis of Ig gene mutation. High molecular weight DNA from 17 PELs was subjected to PCR of the rearranged Ig heavy and light chain genes. Successful amplification was achieved from eight cases (four EBV positive and four EBV negative) and the PCR products were sequenced. All four EBV positive PEL showed variable levels of mutation in their rearranged VH or VL genes, ranging from 4 to 7{\%}. In contrast, two of the four EBV negative PELs including BC3 displayed absence of mutation in their rearranged Ig genes. Our results indicate that EBV positive PELs are derived from germinal centre or post-germinal centre B-cells, whereas EBV negative PELs may originate from either germinal/post-germinal centre or na{\"i}ve B-cells.",
keywords = "EBV, Ig gene, Mutation, Primary effusion lymphoma",
author = "Rifat Hamoudi and Diss, {Tim C.} and Eric Oksenhendler and Langxing Pan and Antonino Carbone and Valeria Ascoli and Chris Boshoff and Peter Isaacson and Du, {Ming Qing}",
year = "2004",
month = "4",
doi = "10.1016/j.leukres.2003.08.003",
language = "English",
volume = "28",
pages = "333--338",
journal = "Leukemia Research",
issn = "0145-2126",
publisher = "Elsevier Ltd",
number = "4",

}

TY - JOUR

T1 - Distinct cellular origins of primary effusion lymphoma with and without EBV infection

AU - Hamoudi, Rifat

AU - Diss, Tim C.

AU - Oksenhendler, Eric

AU - Pan, Langxing

AU - Carbone, Antonino

AU - Ascoli, Valeria

AU - Boshoff, Chris

AU - Isaacson, Peter

AU - Du, Ming Qing

PY - 2004/4

Y1 - 2004/4

N2 - Kaposi's sarcoma-associated herpesvirus (KSHV) is associated with three distinct lymphoproliferative disorders: primary effusion lymphoma (PEL), multicentric Castleman's disease (MCD) and germinotropic lymphoproliferative disorder (GLD). KSHV positive lymphocytes in GLD and in most cases of PEL are co-infected by Epstein-Barr virus (EBV) and these viral double positive cells harbour mutated rearranged immunoglobulin (Ig) genes, suggesting that they originate from germinal centre or post-germinal centre B-cells. In contrast, KSHV positive cells in MCD are invariably negative for EBV, do not carry Ig gene mutation and are believed to originate from naïve IgMλ expressing B-cells. Interestingly, one EBV negative PEL (BC3) also lacks Ig gene mutation, raising the question whether KSHV preferentially targets naïve B-cells in the absence of EBV. We compared the cellular origin of PEL with and without EBV infection by analysis of Ig gene mutation. High molecular weight DNA from 17 PELs was subjected to PCR of the rearranged Ig heavy and light chain genes. Successful amplification was achieved from eight cases (four EBV positive and four EBV negative) and the PCR products were sequenced. All four EBV positive PEL showed variable levels of mutation in their rearranged VH or VL genes, ranging from 4 to 7%. In contrast, two of the four EBV negative PELs including BC3 displayed absence of mutation in their rearranged Ig genes. Our results indicate that EBV positive PELs are derived from germinal centre or post-germinal centre B-cells, whereas EBV negative PELs may originate from either germinal/post-germinal centre or naïve B-cells.

AB - Kaposi's sarcoma-associated herpesvirus (KSHV) is associated with three distinct lymphoproliferative disorders: primary effusion lymphoma (PEL), multicentric Castleman's disease (MCD) and germinotropic lymphoproliferative disorder (GLD). KSHV positive lymphocytes in GLD and in most cases of PEL are co-infected by Epstein-Barr virus (EBV) and these viral double positive cells harbour mutated rearranged immunoglobulin (Ig) genes, suggesting that they originate from germinal centre or post-germinal centre B-cells. In contrast, KSHV positive cells in MCD are invariably negative for EBV, do not carry Ig gene mutation and are believed to originate from naïve IgMλ expressing B-cells. Interestingly, one EBV negative PEL (BC3) also lacks Ig gene mutation, raising the question whether KSHV preferentially targets naïve B-cells in the absence of EBV. We compared the cellular origin of PEL with and without EBV infection by analysis of Ig gene mutation. High molecular weight DNA from 17 PELs was subjected to PCR of the rearranged Ig heavy and light chain genes. Successful amplification was achieved from eight cases (four EBV positive and four EBV negative) and the PCR products were sequenced. All four EBV positive PEL showed variable levels of mutation in their rearranged VH or VL genes, ranging from 4 to 7%. In contrast, two of the four EBV negative PELs including BC3 displayed absence of mutation in their rearranged Ig genes. Our results indicate that EBV positive PELs are derived from germinal centre or post-germinal centre B-cells, whereas EBV negative PELs may originate from either germinal/post-germinal centre or naïve B-cells.

KW - EBV

KW - Ig gene

KW - Mutation

KW - Primary effusion lymphoma

UR - http://www.scopus.com/inward/record.url?scp=1042289339&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1042289339&partnerID=8YFLogxK

U2 - 10.1016/j.leukres.2003.08.003

DO - 10.1016/j.leukres.2003.08.003

M3 - Article

VL - 28

SP - 333

EP - 338

JO - Leukemia Research

JF - Leukemia Research

SN - 0145-2126

IS - 4

ER -